Imcheck Therapeutics
ExitedBiotech solutions company
Imcheck Therapeutics has raised €219M across 4 funding rounds from 11 investors, most recently a round in Jun 2022. Based in Marseille, France; active in Healthtech. Acquired by Ipsen in 2025. Data as of 4 Nov 2026.
Marseille, Francewww.imchecktherapeutics.com ↗
Total raised
€219M
€218,672,973
Funding rounds
4
Investors
11
distinct backers
Active since
2017-05
latest 2022-06
Funding by year
EUR raised per yearImcheck Therapeutics — funding by year — interactive chart.
Data table
| Imcheck Therapeutics — funding by year | |
|---|---|
| 2017 | €20M |
| 2019 | €49M |
| 2020 | €54M |
| 2022 | €96M |
Funding rounds
4 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-06-14 | Other | €96M | Andera Partners,Earlybird Venture Capital,Invus,Leukemia and Lymphoma Society | View deal → |
| 2020-09-15 | Other | €54M | Bpifrance,Pfizer Ventures | View deal → |
| 2019-10-01 | Series B | €49M | Bpifrance,Pfizer Ventures | View deal → |
| 2017-05-09 | Other | €20M | Boehringer Ingelheim Venture Fund,GIMV,IDInvest Partners,Kurma Partners,LSP | View deal → |
Exit
Type
acquisition
Date
Oct 2025
Value
€1.0B
Acquiror
Ipsen (France)
Investors
11Related news
Similar companies
same sector, similar size- Diabeloop€115MFrance · Healthtech
- DNA Script€264MFrance · Healthtech
- DentalMonitoring€244MFrance · Healthtech
- Padoa€105MFrance · Healthtech
- Bioserenity€107MFrance · Healthtech
- Tissium€160MFrance · Healthtech
Global coverage: FundingData